WHO ICTRP trial
Effect of Somatostatin on the Prevention from Pancreatitis and Quality of life…
ChiCTR1900021583 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR1900021583 |
|---|---|
| Public title | Effect of Somatostatin on the Prevention from Pancreatitis and Quality of life of the patients post-ERCP: A randomized controlled trial |
| Scientific title | Effect of Somatostatin on the Prevention from Pancreatitis and Quality of life of the patients post-ERCP: A randomized controlled trial |
| Primary sponsor | Jiangxi Pingxiang People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Acute Pancreatitis |
| Interventions | 1:Somatostatin;2:Placebo |
| Registration date | Feb 28, 2019 |
| Target size | 1:500;2:500 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: